Autres langues Zhejiang CONBA Pharmaceutical Co.,Ltd.

Actions

600572

CNE000001H86

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 17/07/2024			Varia. 5j.	Varia. 1 janv.
4,2 ^CNY	+1,20 %		-5,19 %	-16,83 %

09/07	Zhejiang CONBA Pharmaceutical obtient l'enregistrement de son mucolytique	MT
27/06	CONBA Pharmaceutical obtient le feu vert pour commercialiser les comprimés de tadalafil ; les actions baissent de 3%.	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Zhejiang CONBA Pharmaceutical Gets Drug Registration for Mucolytic	09/07
CONBA Pharma's Unit Gets Nod to Market Antidepressant Drug; Shares Down 3%	27/06
CONBA Pharmaceutical Gets Nod to Market Tadalafil Tablets; Shares Down 3%	27/06
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	19/04
Tranche Update on Zhejiang CONBA Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 23, 2024.	01/04
Shanghai-Listed Firms Actively Repurchase Shares as Regulators Focus on Market Value	02/02
Shanghai Dingjia Trading Co., Ltd. agreed to acquire 20% stake in Shanghai Kede Network Technology Co., Ltd. from Zhejiang CONBA Pharmaceutical Co.,Ltd. for CNY 26 million.	01/02
Zhejiang CONBA Pharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 400 million worth of its shares.	23/01
Zhejiang CONBA Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.	22/01
CONBA Pharma Gets Nod to Trial Cough Medicine	28/11
CONBA Pharma Unit's Acetyl Cysteine Granules Chosen for China's Centralized Drug Procurement	08/11
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Zhejiang CONBA Pharmaceutical Co.,Ltd.(XSSC:600572) added to S&P Global BMI Index	18/09/23
Zhejiang CONBA Pharmaceutical Co.,Ltd.(XSSC:600572) added to FTSE All-World Index	18/09/23
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	04/08/23
Wuxi China Life Chengda Equity Investment Center (Limited Partnership) and Jinhua Future Yicai Phase I Equity Investment Partnership (Limited Partnership) completed the acquisition of 7.84% stake in Jiangxi Zhenshiming Pharmaceutical Co., Ltd. from Zhejiang CONBA Pharmaceutical Co.,Ltd.	07/07/23
CONBA Pharma Gets Drug Registration for Risperidone Oral Solution	25/05/23
Wuxi China Life Chengda Equity Investment Center (Limited Partnership) and Jinhua Future Yicai Phase I Equity Investment Partnership (Limited Partnership) intends to acquire 7.84% stake in Jiangxi Zhenshiming Pharmaceutical Co., Ltd. from Zhejiang CONBA Pharmaceutical Co.,Ltd for CNY 290 million.	29/04/23
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	18/04/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Zhejiang CONBA Pharmaceutical Co.,Ltd.

Actions

600572

CNE000001H86

Autres langues

Filtres